The National Institutes of Health has awarded $2.5 million to the University of Minnesota to fund the “Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics (Minn-KPMP)." Minn-KPMP will be a recruitment site for the Kidney Precision Medicine Project (KPMP), a coalition of leading research teams using precision medicine to develop new therapies for kidney disease. Minn-KPMP is led by Patrick Nachman, MD of the University of Minnesota and Luiza Caramori, MD, PhD of the Cleveland Clinic. Minn-KPMP Co-investigators, Susan Wolf, JD (Consortium Chair) and Jerica Berge, PhD (Department of Medicine), lead research on community engagement and ethical issues raised by KPMP, such as the ethics of research-directed kidney biopsies, return of results, genetic testing, and biobank governance. Working with an expert Ethics Advisory Board, their team will engage a diverse population using community-based participatory research (CBPR) methods to collaboratively study the ethical implications of KPMP research and promote an anti-racist scientific approach.
Thursday, September 29, 2022